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Abstract
Aims—To present three patients with a 
syringomatous carcinoma (SC). SC is a 
rare cutaneous neoplasm, most frequently 
situated on the face and scalp and histo­
logically characterised by an infiltrative 
pattern of basaloid or squamous cells, a 
desmoplastic stromal reaction, keratin 
filled cysts, and granular structures. 
Methods—The clinical histories of the 
patients with a SC were investigated 
retrospectively.
Results—Patient 1 had a benign appearing 
tumour of the lower eyelid. Five tumour 
excisions were necessary to remove the SC 
completely. Patient 2 had a tumour on the 
lateral part of the lower eyelid and in the 
medial canthal area. The histopathologi­
cal findings revealed a squamous cell car­
cinoma, later revised as a SC. In spite of 
two excisions and one microscopically 
controlled excision, a recurrence oc­
curred. An exenteration orbitae was rec­
ommended. Patient 3, known to have a 
history o f multiple malignant skin tu­
mours after kidney transplantation and 
use of cyclosporin, presented with a firm  
mass in the eyebrow region and in the 
nasal area of the orbit. The pathological 
diagnosis of this adnexal tumour was 
difficult. An exenteration was recom­
mended.
Conclusions—SC is a benign appearing 
but extremely invasive, locally destruc­
tive, slowly growing adnexal tumour, de­
rived from eccrine sweat glands. It is often 
mistaken, both clinically and microscopi­
cally, for other benign and malignant enti­
ties. The tumour recurrence is high due to 
extensive perineural invasion, but re­
gional or distant metastases are rare. The 
local aggressive nature of the tumour and 
the high recurrence rate may necessitate 
mutilating procedures. Optimal treat­
ment consists of a complete microscopi­
cally controlled surgical excision with 
clear surgical margins.
(Br J  Ophthalmol 1997;81:668-672)
Syringomatous carcinoma is a rare malignant 
skin appendageal tumour derived from sweat 
glands, first described by Goldstein et al in 
1982 as a microcystic adnexal carcinoma (see 
Table l ) .1'2 Since it was recognised there has 
been much controversy about its nomencla­
ture. Since 1970, a variety of synonyms have 
been given to some carcinomas with eccrine 
differentiation, among them syringoid eccrine
carcinomas, microcystic adnexal carcinoma, 
malignant syringoma, sclerosing sweat duct 
(syringomatous) carcinoma, and sweat gland 
carcinoma with syringomatous features.310 It is 
currently believed that these are different 
names for the same neoplastic process with 
different degrees of differentiation. The entire 
group is termed ‘syringomatous carcinoma’, 
characterised by cutaneous involvement, inva­
sive destructive local growth, skeletal muscle, 
and perineural invasion.1
We describe three patients with a syringoma­
tous carcinoma of the eyelid and in the perior­
bital region, demonstrating the local aggressive 
nature of this tumour. The purpose of this 
study was to describe the clinical features, the 
histopathological findings, the treatment, and 
the difficulties encountered in diagnosing this 
tumour, both clinically and histopathologi- 
cally, in our patients.
Case reports
CASE 1
A 50-year-old woman presented at the Aca­
demic Hospital Utrecht with an irritating and 
itching cutaneous nodule on the medial part of 
the right lower eyelid. The nodule measured 5 
X 4 mm, was painless, benign appearing, firm, 
and involved the lid margin just near the 
lacrimal punctum. For cosmetic reasons, the 
patient underwent surgical excision of the 
benign appearing tumour under local anaes­
thesia. However, histopathological examin­
ation revealed a moderately differentiated 
syringomatous carcinoma which was not com­
pletely remoyed. One month later, a wide full 
thickness excision of the lower eyelid was 
performed. The specimen measured 9 x 6  mm 
and only the medial part of this specimen 
appeared to be free of tumour. During the next 
month, two more excisions were performed 
and again the lateral margins of the specimen 
were not free of tumour. Two weeks after the 
last surgery, a full thickness excision of the 
complete lower eyelid and excision of some 
periorbital tissue were necessary to remove the 
tumour completely. One month after the com­
plete re-excision, the lower eyelid was recon­
structed. The histopathological findings 
showed a syringomatous pattern (Fig 1), and 
neoplastic epithelial cells arranged in intercon­
necting cords with microcystic areas. Nests, 
cords, and tubules of the tumour extended into 
the dermis and into the orbicularis muscle (Fig 
2, 3, and 4). There was extensive perineural 
infiltration by neoplastic cells (Figs 5). Sclero­
sis of stroma around the cords was present. 
Tumour cells were not connected to the 
epidermis. The immunohistochemical analysis
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Figure 1 Syringoma (a benign sweat gland tumour), showing the characteristic 
syringomatous pattern. Numerous small comma-shaped ducts are embedded in fibrous 
stroma. Amorphous eosinophilic debris is often within the ductal luniina. Anaplasia and 
invasion are not observed in benign sweat gland tumour The benign tumour does not show 
perineural, subcutaneous or muscle infiltration (in contrast with the syringomatous 
carcinoma) . Magnification x 192,
Figure 2 Survey light micrograph of a specimen of the lower eyelid of patient 2, 
demonstrating a syringomatous carcinoma infiltrating in muscle ( asterisk) and between 
sebaceous structures (arrowheads). The area between the circles is magnified in Figure 3, 
Magnification x 30.
showed positivity for anti-EMA
excisional biopsy from the first lesion revealed 
a squamous cell carcinoma and from the 
second lesion a Bowen’s disease. The lesions 
were treated by ionising radiation. Eight 
months later, the patient was referred to the 
department of ophthalmology of the Academic 
Hospital Nijmegen with a firm, plaque-like 
lesion with poorly circumscribed margins, 
telangiectasias, and central ulceration at the 
lower eyelid. After an incisional biopsy of the 
lateral canthus and an excisional biopsy of the 
medial part of the eyelid, the lower 
reconstructed. Pathological examination of the 
incisional biopsy showed a squamous 
carcinoma while the excisional biopsy showed 
a moderately differentiated squamous cell car-
was
merging
syringomatous carcinoi 
The resected specimen; 
firm complete excision.
microscopically 
was performed
frozen section control. Most 
evelid, the lateral canthus, ar
the lower 
art of the
upper eyelid were excised. The pathological
findings
squamo id
and
matous
domly dispersed in a dense oedematous 
collagenous stroma. In some specimens, 
branching of tubular structures and aggrega­
tions of neoplastic cells gave comma-like 
shapes. The microcysts contain lamellated 
keratinaceous material resembling hair matrix,
some may demonstrate extensive 
squamous metaplasia. Perineural infiltration of 
tumour cells was present. The immunohisto 
chemical analysis was consistent with syringo
carcinoma (see case 1). Although the 
superficial part of the tumour showed some 
aspects of a squamous cell carcinoma, the 
overall picture of the specimens disclosed a 
syringomatous carcinoma. This diagnosis was 
confirmed by re-evaluating previous speci­
mens. Unfortunately, the tumour extended to 
the margins of resection. Four months later, 
the specimen of an incisional biopsy revealed a 
recurrence of the tumour. The patient’s best 
corrected visual acuity was 0.4 in both pseudo- 
phakic eyes. Although orbital exenteration with 
micro scopic
advised, the pat ent declined am furthermembrane antigen, dilution 1:50, Dako, Glas-
trup, Denmark), anti-CEA (carcinoembryonic surgery. Radiotherapy of the involved area was
antigen, dilution 1:100, Bio Genex, San performed.
Ramon USA), AE1/AE3 (cytokeratins, dilu­
tion 1:200 in an overnight incubation protocol c a s e  3
at 4°C, Bio Genex, San Ramon, USA), and A 54-year-old man had an elaborate clinical
S I00 protein (expressed by eccrine sweat gland history including two kidney transplants in
cells, dilution 1:5000, Glostrup, Denmark) 1970 and 1990 with cyclosporin treatment to
(see Discussion). These histological and im- prevent rejection. Between 1983 and 1995, the
munohistochemical analyses were consistent patient developed several benign lesions (nae-
with the diagnosis of syringomatous eccrine vus naevocellularis, papillomas), premalignant
carcinoma.
CASE 2
A 83-year-old white woman presented with a
lesions (actinic keratosis), and multiple malig­
nant tumours of the skin, such as squamous 
cell carcinomas (right eyelid, temple, back of 
the hand, neck, preauricular skin, back, wrists,
slow growing, crusty, painless, plaque-like nostril, forehead, right medial canthal area, and
lesion at the lateral 3/4 side of the right lower many recurrences) and basal cell carcinomas
eyelid and a second isolated erythematous (upper arm, nose, neck, temple, under arm,
crusty nodule in the medial lower eyelid and nostril, and recurrences) (Fig 6). Initial biopsy
medial canthal region of the same side. An of the tumour present in the medial canthal
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Figure 3 Detail of the syringomatous carcinoma (see Fig 2) with tubules simulating 
syringoma and less differentiated cords. Magnification x 120.
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Figure 4 Syringomatous carcinoma: detail of muscle infiltration. Magnification x 300.
Figure 5 Syringomatous carcinoma: detail of perineural invasion (arrowheads) . 
Magnification x 300.
and eyebrow region was interpreted as an
carcinoma
patient was referred to the Academic Hospital
mm
chemosis
of the
0.9 in the 
firm mass
in the nasal area. A magnetic resonance image 
scan showed that the tumour invaded the
*
medial aspect of the right orbit near the troch- 
lea3 with invasion into the frontal bone. The 
biopsy specimen was re-examined and again a 
syringoid eccrine carcinoma was diagnosed.
consultation
s squamous c 
with several orbital teams, an
exenteration of the orbital contents was recom-
ofthe
the
therapy
malignancies and the radiation induced im­
pairment of vision restrain us from performing 
this therapy. It was decided to apply palliative 
therapy if necessary.
Difficulties in diagnosing were present. The 
specimens from the medial canthus area and 
forehead were reevaluated by other patholo­
gists (Erasmus University, Rotterdam). The 
specimens revealed a squamoid tumour, with­
out microcystic differentiation, and no connec­
tion of tumour to the epidermis. Within the 
tumour, there was local presence of hair, some 
mitotic figures, a marked perineural invasion,
atypical
desmoplastic stroma. Some
The tumour cells were strongly positive for 
anti-cytokeratin and anti-EMA, and negative 
for CEA and for S100. This picture was 
consistent with an adnexal carcinoma with 
pilar differentiation.
Discussion
The ocular adnexa include hair follicles, 
sebaceous glands (meibomian, Zeis, and 
caruncle glands), and sweat glands (apocrine 
and eccrine). The vast majority of the condi­
tions are fortunately benign. However, some 
are malignant and may have aggressive fea­
tures. A general categorisation of adnexal 
tumours is given in Table 1.
Syringomatous carcinoma (SC) is derived 
from the sweat glands and is characterised by 
tubular features and eccrine differentiation, 
which can, according to Abenoza and Acker­
man, be classified further as: (1) well differen­
tiated SC (main synonym: microcystic adnexal 
carcinomas), (2) moderately differentiated SC, 
and (3) poorly differentiated SC. Many syno­
nyms can be found in literature,1 but they 
probably represent the same neoplastic process 
with different degrees of differentiation. The 
well differentiated form is most frequently 
found than the other two forms and will there­
fore be discussed below.
CLINICAL FEATURES
The sex distribution is about equal.11 The 
patients present most frequendy in the fourth 
and fifth decades of life (age range 20s to 
80s).1212 Many patients have been aware of the
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Clinically5 lesions usually manifest as a 
slowly growing, flesh or pale/yellow coloured, 
solitary, firm, indurated nodule or plaque, 
often with diffuse, ill defined margins and 
overlying telangiectasia. The overlying epider­
mis may appear normal, atrophic, or scaly. 
Ulceration is unusual. The clinical differential 
diagnosis includes morphea-like basal cell car­
cinoma. Clinical and histopathological evalua­
tion have to be performed for these imitations 
of eyelid tumours.1(1
'■■■■■:':-0iM
mm
-wm 
»p»
••ir.mi 7?:V■mm
m
■
■ -■ ■ im
Figure 6 Patient 3 with multiple malignant tumours of the skin, such as squamous cell 
carcinomas (right eyelid> temple} neck, preauricular skin, nostril, foreheadA right medial 
canthal area) and basal cell carcinomas (nose, neck, temple, nostril). A  firm mass zvas 
palpable in the nasal area (arrow).
Table 1 Adnexal tumours (located on eyelids)
I
H ISTO PA TH O LO G ICA L FIN D IN G S
The microscopic appearance of SC mimics 
that of several benign sweat gland tumours, 
including benign syringoma (Fig 1). The main 
characteristics are syringomatous pattern (Fig 
1) (including formation of tubules), formation 
of cysts containing cornefied cells, extensions 
of neoplastic cells into subcutaneous tissues, 
sclerotic stroma, and rare or absent mitosis. SC 
is basically composed of nests, cords (mostly 
interconnecting), tubules, and cysts of cyto- 
logically uniform, cuboidal, or flattened squa- 
moid cells that are randomly dispersed in a 
dense collagenous stroma (desmoplasia) (Figs 
2 and 3). Branching of tubular structures and 
aggregations of tumour cells that have the 
shapes vaguely resembling ‘tadpoles’ or ‘com­
mas’ are seen. The histological diagnosis can 
be confirmed by immunohistochemical analy­
sis: positivity for anti-EMA, anti-CEA, and 
S I00 protein is consistent with adnexal tu­
mour with sweat gland differentiation.1 217-19
Perineural and intraneural invasion is a 
common and a particularly characteristic find­
ing in SC (Fig 5).” The SC extend deep into 
the dermis, often into subcutaneous fat, 
commonly into skeletal muscle (Fig 4), and 
sometimes into perichondrium, bone, vascular 
adventitia.” U) 2I)*22 The invasive tumour is lo­
cally destructive but regional lymph node or 
distant metastases have not been observed in 
well differentiated SC. Only one reported 
patient developed carcinoma in a lymph node, 
probably by direct perineural extension from 
the adjacent primary neoplasm." It is possible 
that our patient 2 has an SC of die eyelid with 
existence of the neoplasms for many years orbital involvement. In case 3, the tumour was 
before they seek consultation.7 9 11 SC are very invasive and extended deep into the orbit.
II
i n
IV
Sweat glands:
(a) Apocrine tum ours:
Benign: hidrocystom a
syringocystadenoma papilliferum 
hidradenom a papilliferum 
adenom a 
cylindroma
M alignant: adenocarcinoma (of die gland of
Moll)
(b) Eccrine tum ours
Benign: hidrocystoma
syringoma
chondroid syringoma (mixed 
tum our)
acrospiroma (clear cell 
hidradenom a) 
spiradenoma
malignant forms o f  ‘benign eccrine 
tum ours’
prim ary mucinous carcinoma 
(adenocystic)
prim ary infiltrating signet ring 
carcinoma
sclerosing sweat duc t carcinoma or 
syringomatous carcinoma 
Pilar tum ours (hair follicles)
Sebaceous tum ours
Lesions simulating prim ary adnexal tum ours
Malignant:
mostly situated on the head and neck with a A correct
predilection for the centrofacial region (about importance
is of
local
85%) (mainly upper and lower lip). Less nature of the tumour. Many difficulties are
frequent sites include the eyebrow region, the encountered in diagnosing this tumour
nasolabial fold, nose, cheek, scalp, chin, and histopathologically.1 15 When the architectural
periorbital skin. Although the face is the most pattern is not present (shaved off or superfi-
common site for well differentiated syringoma- dally punched out specimen), the characteris-
tous carcinomas, the moderately differentiated tic histological features may not be apparent
and the neoplasm can easily be misinterpreted 
as syringomas, trichoepitheliomas, or tricho- 
adenomas, or squamous cell carcinoma. In
ones are mostly situated on the scalp and, 
rarely, on the face.1 Until now, only six cases of 
‘microcystic adnexal carcinoma’ (the well
differentiated form of SC) were reported in the case 2, the biopsy performed contained super 
orbital area, involving the eyebrow region 
(three cases),13' 15 the lower eyelid (two cases),10 
and upper eyelid (one case).15 In our two cases. Later, a wider excision biopsy revealed an SC. 
the neoplasm was located in the lower eyelid If the architectural pattern is indicative of a 
with periorbital invasion. One immunocom- malignant neoplasm but ductal differentiation 
promised patient (case 3) showed eyebrow/ is overlooked, an erroneous diagnosis of 
upper eyelid and secondary orbital involve- morphea-like basal cell or squamous cell carci- 
ment. noma is made as occurred in two of our
ficial tissue only and, therefore, the 
located SC was not present in the specimen.
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patients. Case 3 showed that various malignant 
skin and adnexal carcinomas may exist in the 
same patients (Fig 6). It is possible that these 
tumours were induced by the immunosuppres­
sive agent cyclosporin. The eyelid/eyebrow 
tumour in this patient was a squamoid tumour 
without apparent eccrine differentiation, which 
has been diagnosed consecutively as squamous 
cell carcinoma, eccrine carcinoma with 
squamous cell carcinoma, and eventually as 
adnexal carcinoma with pilar differentiation. In 
the study of Leboit and Sexton, nine of 17 
lesions were initially misdiagnosed because of 
the small size of the biopsy specimen.15
TREATMENT
Surgical excision is the oldest and probably the 
most reliable method of eradicating carcino­
mas of the eyelid. Because SCs tend to 
infiltrate far beyond the clinical margins of the 
neoplasm, surgical excision should be wider 
and deeper than anticipated and the excised 
specimens should be assessed carefully by the 
pathologist. Complete surgical excision under 
microscopical control must be performed.
Perineural invasion is frequently present in 
SC and may account for the high frequency of 
incomplete excision and local recurrence. In 
the literature, about 40-60% of patients had 
one or more local recurrences within 6 months 
to 30 years after treatment with standard wide 
local excision1 9 11 12 23 Recurrent SC has to be 
treated by microscopically controlled surgery.24 
When a SC infiltrates into the orbital fat or 
when perineural orbital involvement is de­
tected, orbital exenteration has to be consid­
ered (see cases 2 and 3). In case 2, exenteration 
was advised but radiotherapy was eventually 
performed for different reasons, such as age 
and patient’s preference. In the literature, 
radiation therapy is rarely applied and was used 
in three cases for the treatment of primary 
microcystic adnexal carcinoma.2 20 25 In two 
cases, results were documented and both had a 
recurrence within 2.5 to 3 years after 
radiotherapy.20 25
Conclusion
SC is a rare, benign appearing but extremely 
invasive, locally destructive, slowly growing 
adnexal tumour. It may be mistaken clinically 
and microscopically for other benign and 
malignant entities. A delayed recognition, an 
incorrect initial histological interpretation of 
lesions, a standard surgical excision, and 
routine histopathological examination of ex­
cised tumour increase the risk of recurrence
and morbidity or mortality. The aggressive 
tumour may result in mutilating procedures, 
such as orbital exenteration. Only tumour free 
margins of the excised tissue portend a favour­
able prognosis.9
The authors thank Dr Van Der Putte, pathologist of the depart­
ment of pathology in the Academic Hospital Utrecht, for 
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